Genomics Reveals Causes of Cerebral Palsy

• November 6, 2026

FDA raises TMB threshold for pembrolizumab

Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.

• by Mouj Hijazi

• October 23, 2026

• 3 min

Two Generations, Two Countries, One Calling

The story of a father’s belief and a daughter’s journey in pathology

• by Hansini Laharwani

• November 5, 2026

• 4 min

A Moment for Reflection

Gregory G. Davis reflects on a year of challenges and optimism as President of ASCP

• by Gregory G. Davis

• November 2, 2026

• 4 min